You are here: Home » Companies » News
Business Standard

SII, Bharat Biotech welcome enhanced focus on health in Budget 2021

Serum Institute of India and Bharat Biotech applauded the government's increased allocation for the healthcare sector and on providing Rs 35,000 crore towards Covid-19 vaccination in 2021-22 fiscal.

Topics
Serum Institute of India | Bharat Biotech | Budget 2021

Press Trust of India  |  New Delhi 

Jabalpur: A medic administers the first dose of Covishield vaccine to a frontline worker, after the launch of Covid-19 vaccination drive at Victoria Hospital in Jabalpur, Jan. 16, 2021. (PTI Photo)

Leading vaccine manufacturers and on Monday applauded the government's increased allocation for the healthcare sector and on providing Rs 35,000 crore towards COVID-19 vaccination in 2021-22 fiscal.

"I have provided Rs 35,000 crore for COVID-19 vaccine in this year 2021-22. I'm committed to provide further funds if required. The Budget outlay for health and well being is Rs 2.23 lakh crore in 2021-22 as against BE of Rs 94,452 crore and marks an increase of 137 per cent," she said while presenting 2021-22 Budget in the Lok Sabha.

Commenting on the budget announcements, CEO Adar Poonawalla said that globally, spending on healthcare infrastructure and vaccines have given countries and their economies the best bang for their buck.

Investments in these areas have prevented hospitalisations and resulted in a healthier and more productive workforce, thereby leading to an efficient economy, he added.

"Therefore we welcome the FM's emphasis on healthcare spending, and immunisation especially for COVID-19 and the pneumococcal vaccines as this will help India recover rapidly from this pandemic. Hopefully, this will also encourage more innovation and expansion in the sector," Poonawalla said.

In a similar vein, Chairman & MD Krishna Ella said, "It's a great step ahead, and far-reaching budget announcement, providing Rs 35,000 crore for COVID-19 vaccination in 2021-22".

The Finance Minister's commitment for providing more funds in order to contain the coronavirus pandemic spread in the country and to provide an effective, smooth path for the vaccination scheme will help contain, and lead the nation towards accomplishing a COVID-19 disease free Bharat, he added.

"The layout plan of a Rs 64,180 crore spending plan for healthcare over the next six years to be spent on primary, secondary and tertiary healthcare, in addition to the National Health Mission is also a welcome move, which will strengthen public health services as 17,000 rural and 11,000 urban health and wellness centres and integrated public health labs to be set up in each district", Ella said.

The government's focus on three areas - preventive health, curative health and well-being, is also very reassuring, he added.

India had earlier in January approved two vaccines -- Oxford-AstraZeneca COVID-19 vaccine, 'Covishield' manufactured by SII and Bharat Biotech's Covaxin -- for restricted emergency use.

The country launched its COVID-19 vaccination drive from January 16 in what Prime Minister Narendra Modi has called the world's largest vaccination drive.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, February 01 2021. 18:35 IST
RECOMMENDED FOR YOU